Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Year-over-year net income growth rate
Latest
-147.73%
↓ 544% vs avg
Percentile
P5
Near historical low
Streak
1 qtr
Consecutive declineDecelerating
Average
33.24%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -147.73% |
| Q3 2025 | 716.74% |
| Q2 2025 | -83.62% |
| Q1 2025 | 2825.25% |
| Q4 2024 | -108.81% |
| Q3 2024 | -68.14% |
| Q2 2024 | -53.16% |
| Q1 2024 | 107.46% |
| Q4 2023 | -2640.39% |
| Q3 2023 | 114.57% |
| Q2 2023 | -17.42% |
| Q1 2023 | 164.49% |
| Q4 2022 | -4.23% |
| Q3 2022 | -106.47% |
| Q2 2022 | 925.04% |
| Q1 2022 | 124.78% |
| Q4 2021 | 19.45% |
| Q3 2021 | -26.65% |
| Q2 2021 | 11.19% |
| Q1 2021 | -18.68% |
| Q4 2020 | -17.93% |
| Q3 2020 | 7.04% |
| Q2 2020 | -325.56% |
| Q1 2020 | 70.22% |
| Q4 2019 | -7.11% |
| Q3 2019 | 7.79% |
| Q2 2019 | 8.64% |
| Q1 2019 | -39.18% |
| Q4 2018 | -40.85% |
| Q3 2018 | -18.70% |
| Q2 2018 | -28.56% |
| Q1 2018 | 12.36% |
| Q4 2017 | 0.69% |
| Q3 2017 | 1.43% |
| Q2 2017 | -42.03% |
| Q1 2017 | -10.35% |
| Q4 2016 | 21.40% |
| Q3 2016 | 1.28% |
| Q2 2016 | -34.55% |
| Q1 2016 | 29.98% |